Evidence map›Paper›PMID 32303238›Full record

ArticleJournal of neuroinflammation2020

CD4+ T cell expression of the IL-10 receptor is necessary for facial motoneuron survival after axotomy.

Elizabeth M Runge, Abhirami K Iyer, Deborah O Setter, Felicia M Kennedy, Virginia M Sanders, Kathryn J Jones

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Elizabeth M RungeDepartment of Anatomy, Cell Biology, and Physiology, Indiana University School of Medicine, 635 Barnhill Drive, Medical Science Building 5035, Indianapolis, IN, 46202, USA. erunge@iu.edu.
Abhirami K IyerDepartment of Neuroscience, Washington University School of Medicine, St. Louis, MO, USA.
Deborah O SetterDepartment of Anatomy, Cell Biology, and Physiology, Indiana University School of Medicine, 635 Barnhill Drive, Medical Science Building 5035, Indianapolis, IN, 46202, USA.
Felicia M KennedyDepartment of Anatomy, Cell Biology, and Physiology, Indiana University School of Medicine, 635 Barnhill Drive, Medical Science Building 5035, Indianapolis, IN, 46202, USA.
Virginia M SandersDepartment of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.
Kathryn J JonesDepartment of Anatomy, Cell Biology, and Physiology, Indiana University School of Medicine, 635 Barnhill Drive, Medical Science Building 5035, Indianapolis, IN, 46202, USA.
Richard L. Roudebush VA Medical Center · USIndiana University – Purdue University Indianapolis · USIndiana University School of MedicineThe Ohio State University · USWashington University in St. Louis · US

Funding

Indiana Medical Scientist/Engineer Training ProgramT32GM077229 · NIGMS · INDIANA UNIVERSITY INDIANAPOLIS · PI GASTON, BENJAMIN, HERBERT, BRITTNEY-SHEA · 2008 to 2022
$6.0M
Immune Regulation of Neuronal Injury and RepairR01NS040433 · NINDS · LOYOLA UNIVERSITY CHICAGO · PI JONES, KATHRYN JANE · 2001 to 2017
$5.9M
NIGMS NIH HHS T32 GM077229NINDS NIH HHS NS40433
6 · The paper itself

Abstract

backgroundAfter peripheral nerve transection, facial motoneuron (FMN) survival depends on an intact CD4+ T cell population and a central source of interleukin-10 (IL-10). However, it has not been determined previously whether CD4+ T cells participate in the central neuroprotective IL-10 cascade after facial nerve axotomy (FNA).

methodsImmunohistochemical labeling of CD4+ T cells, pontine vasculature, and central microglia was used to determine whether CD4+ T cells cross the blood-brain barrier and enter the facial motor nucleus (FMNuc) after FNA. The importance of IL-10 signaling in CD4+ T cells was assessed by performing adoptive transfer of IL-10 receptor beta (IL-10RB)-deficient CD4+ T cells into immunodeficient mice prior to injury. Histology and qPCR were utilized to determine the impact of IL-10RB-deficient T cells on FMN survival and central gene expression after FNA. Flow cytometry was used to determine whether IL-10 signaling in T cells was necessary for their differentiation into neuroprotective subsets.

resultsCD4+ T cells were capable of crossing the blood-brain barrier and associating with reactive microglial nodules in the axotomized FMNuc. Full induction of central IL-10R gene expression after FNA was dependent on CD4+ T cells, regardless of their own IL-10R signaling capability. Surprisingly, CD4+ T cells lacking IL-10RB were incapable of mediating neuroprotection after axotomy and promoted increased central expression of genes associated with microglial activation, antigen presentation, T cell co-stimulation, and complement deposition. There was reduced differentiation of IL-10RB-deficient CD4+ T cells into regulatory CD4+ T cells in vitro.

conclusionsThese findings support the interdependence of IL-10- and CD4+ T cell-mediated mechanisms of neuroprotection after axotomy. CD4+ T cells may potentiate central responsiveness to IL-10, while IL-10 signaling within CD4+ T cells is necessary for their ability to rescue axotomized motoneuron survival. We propose that loss of IL-10 signaling in CD4+ T cells promotes non-neuroprotective autoimmunity after FNA.

Indexed as

AnimalsAxotomyCD4-Positive T-LymphocytesCells, CulturedCell SurvivalFacial NerveFacial Nerve InjuriesFemaleGene ExpressionMiceMice, 129 StrainMice, Inbred C57BLMice, KnockoutMice, TransgenicMotor NeuronsReceptors, Interleukin-10Receptors, Interleukin-10AutoimmuneAxotomyIL-10MotoneuronNerve injuryNeuroprotectionT cell

Identifiers

PMID32303238
PMCPMC7164177
OpenAlexW3016394118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.